M&A Deal Summary

Phibro Acquires MVP Laboratories

On January 12, 2016, Phibro acquired medical products company MVP Laboratories

Acquisition Highlights
  • This is Phibro’s 1st transaction in the Medical Products sector.
  • This is Phibro’s 1st transaction in the United States.
  • This is Phibro’s 1st transaction in Nebraska.

M&A Deal Summary
Date 2016-01-12
Target MVP Laboratories
Sector Medical Products
Buyer(s) Phibro
Deal Type Add-on Acquisition

Target

MVP Laboratories

Omaha, Nebraska, United States
MVP Laboratories, Inc. is a developer, manufacturer and marketer of livestock vaccines, vaccine adjuvants and other products.

Search 199,713 Deals Now

SEARCH BY

  • Buyer Type (PE or Strategic)
  • Deal Size ($10M to $10B+)
  • Sector (60 Sectors)
  • Deal Type
  • Geography
  • & More

Try For Free 7-Day Free Trial

Buyer(S) 1

Buyer

Phibro

Teaneck, New Jersey, United States
Category Company
Founded 2014
Sector Food
Employees1,700
Revenue 1.0B USD (2024)
DESCRIPTION

Phibro is a global diversified animal health and mineral nutrition company. Phibro develops, manufactures and markets a broad range of products for food animals including poultry, swine, beef and dairy cattle and aquaculture. Phibro's products help prevent, control and treat diseases, enhance nutrition to help improve health and contribute to balanced mineral nutrition. Phibro was founded in 2014 and is based in Teaneck, New Jersey.

DEAL STATS #
Overall 1 of 5
Sector (Medical Products) 1 of 2
Type (Add-on Acquisition) 1 of 4
State (Nebraska) 1 of 1
Country (United States) 1 of 3
Year (2016) 1 of 1
FOLLOWING DEAL
DATE TARGET DEAL TYPE VALUE
2017-09-11 Biotay S.A

Buenos Aires, Argentina

Biotay S.A is privately held developer, manufacturer and marketer of animal health and nutritional products based in Argentina.

Buy -
Mergr

Product

Company

Legal